Talaris Therapeutics's current assets is $250M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2025), TALS shows a current assets of $250M. That compares with $300M in the prior-year period — down 16.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, TALS's current assets is now $250M (was $300M) — a 16.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Talaris Therapeutics is outperforming or lagging.
Tracking TALS's current assets over time shows whether Talaris Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $250M That compares with $300M in the prior-year period — down 16.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current assets page, Stockcircle has Talaris Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $250M) with ownership activity and broader fundamentals.
Talaris Therapeutics's current assets is $250M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.